Search Results - R. Kaedbey

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY. by F. Khadadah, A. G. Turkina, E. Lomaia, E. V. Morozova, O. A. Shukhov, A. Petrova, T. Chitanava, J. J. Vlasova, E. Kuzmina, I. Nemchenko, E. Y. Chelysheva, A. Bykova, M. Gurianova, A. Xenocostas, L. Busque, K. Jamani, S. Cerquozzi, P. Kuruvilla, R. Kaedbey, B. Leber, S. Assouline, D. D. H. Kim

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma... by A. Visram, A. De La Torre, D. White, J. Su, E. Masih-Khan, M. Chu, V. Jimenez-Zepeda, A. McCurdy, R. LeBlanc, K. Song, H. Mian, M. Louzada, M. Sebag, D. Bergstrom, J. Stakiw, A. Reiman, R. Kotb, M. Aslam, C. Venner, R. Kaedbey, E. Gul, D. Reece

    Published in Blood Cancer Journal (2023-12-01)
    Get full text
    Article


Search Tools: